Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.060
+0.020 (0.98%)
Sep 17, 2026, 4:10 PM AEST
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 2.68 billion as of September 16, 2026. Its market cap has decreased by -10.69% in one year.
Market Cap
2.68B
Enterprise Value
2.71B
Revenue
173.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.06
ChartMarket Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 2.68B, an increase of 3,393.64%. That is a compound annual growth rate of 17.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 2.68B | -23.34% |
| Dec 31, 2025 | 3.49B | -1.80% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 6.03B |
| Neuren Pharmaceuticals | 2.63B |
| PYC Therapeutics | 2.19B |
| Clarity Pharmaceuticals | 817.05M |
| Clinuvel Pharmaceuticals | 421.58M |
| Racura Oncology | 392.14M |
| Starpharma Holdings | 355.25M |
| Tetratherix | 336.39M |